Search

everythinglearnresearchcommunity

for

Search:↓

Olive oil compounds may help prevent cancer in animals, but human results are mixed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

PRP therapy helps slow hair loss and increases hair thickness.

Medications for PCOS don't seem to raise heart disease risk.

Blue light might help treat skin conditions by affecting the skin's bacteria.

Lasers are less favored for hair transplant surgery but show promise for hair growth in controlled trials.

Too much Smad7 can cause serious changes in skin tissues, including problems with hair growth, thymus shrinkage, and eye development issues.

The document suggests that the traditional understanding of hair growth cycles and alopecia may be inaccurate and that blood supply plays a significant role in hair growth and loss.

The document explains the genetic causes and characteristics of inherited hair disorders.

Glycogen levels in mouse skin drop after injury but increase during healing, returning to normal within a month.

Boxer dogs may have a genetic skin condition that worsens seasonally and can be treated with certain medications.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

ApoBDs, once seen as waste, are now viewed as potential tools for disease treatment and tissue repair.

Understanding different species' regeneration can improve mammalian healing.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Ziziphus jujuba Mills may have health benefits, but more research is needed to confirm its safety and effectiveness.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

The document concludes that products like PRP and PRF show promise for tissue healing, but evidence of their effectiveness is inconsistent.

Taking Propecia might lead to the development of cataracts.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Finasteride, often used for hair loss, can potentially cause cataracts.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

Multiomics helps understand and improve skin healing and repair.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Higher p63 and CD34 levels found in specific scalp areas may affect hair loss progression.